Closed System Transfer Device (CSTD) Market Current Scenario Trends, Comprehensive Study and Regional Forecast to 2027
Research Reports
Jun 15, 2021
Global Closed System Transfer Device (CSTD) Market was valued at USD 395 million by 2020 which is expected to reach USD 1,751.83 by 2027 at a CAGR 21.2% from 2020to 2027 during the forecast period.
The latest published report by Qualiket Research is Global Closed System Transfer Device (CSTD) Market Size, Trends & Growth Opportunity, By Type (Membrane-To-Membrane Systems, and Needleless Systems), By Component (Vial Access Devices, Syringe Safety Devices, Bag/Line Access Devices and Accessories), By Technology (Diaphragm-Based Devices, Compartmentalized Devices, and Air Cleaning/Filtration Devices), By End User(Hospitals, Oncology Centers & Clinics, Others), By Region and Forecast till 2027provides a detailed insight into current market dynamics & analysis on the future market growth.
Request a Sample Copy of the Research Report @ https://qualiketresearch.com/request-sample/Closed-System-Transfer-Device-CSTD-Market/request-sample
Key Players
Top players covered in the Global Closed System Transfer Device (CSTD) Market include ICU Medical, Inc., Equashield LLC, Corvida Medical, B. Braun Melsungen AG, Yukon Medical, Becton, Dickinson and Company, Baxter International Inc., Caragen Ltd, JMS CO., LTD., VICTUS, etc. Each of this key player has been profiled in the report based on parameters such as company overview, financial overview, business strategies, business segments, product portfolio, and recent developments.
A closed system drug transfer device is defined as a medical device which mechanically prevents the transfer of environmental contaminants into a system & the escape of hazardous drug or vapor concentrations outside the system. This is also called as closed system drug-transfer device. These devices ensure healthcare workers safety during the usage of hazardous drugs or chemicals.
Get your Customized Research Report @ https://qualiketresearch.com/request-sample/Closed-System-Transfer-Device-CSTD-Market/ask-for-customization
Recent Development
In April 2020: Corvida Medical had signed distribution agreement with the Fresenius Kabi (global healthcare company) for the United Sates. Under this agreement Fresenius Kabi will distributes HALO Closed System Drug-Transfer Device (CSTD)which is manufactured by Corvida Medical. It is an airtight and leak-proof closed system drug transfer device (CSTD) which mechanically prohibits the transfer of environmental contaminants into the system & the escape of drug or vapor concentrations outside the system.
Impact of COVID-19 on Market
The increase in COVID-19 cases across the globe is expected to significantly affect the overall development of the global closed system transfer devices (CSTD), mainly in the first half of the forecast period. Fluctuating economies across the globe, stringent border control as well as lockdowns in several nations affected the global pharmaceutical supply chain in 2020.
Inquire To Know More About This Report @ https://qualiketresearch.com/request-sample/Closed-System-Transfer-Device-CSTD-Market/inquire-before-buying
Tags:
, Menafn, Reportedtimes, Research Newswire, English